Journal of the National Cancer Institute
DC-SCRIPT found to have prognostic value in breast cancer
Published in Oncology Business Week, January 3rd, 2010
In this study, a team led by Gosse J. Adema, Ph.D., of the Department of Tumor Immunology, at the Radboud University Nijmegen Medical Centre, the Netherlands, and colleagues assessed the role of DC-SCRIPT as a co-regulator of nuclear receptors, including estrogen receptor (ER), progesterone receptor (PR)-B, peroxisome proliferator-activated receptor gamma, and retinoic acid receptor alpha. Prognostic value was assessed in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- 1 Million Against Cancer
A Cancer Victim's Dying Wish Sends a Powerful Message to the World with the Launch of 1MillionAgainstCancer.org - Abraxis BioScience, Inc.
Abraxis Provides Overview of ABRAXANE(R) Study Results to Be Presented at the 32nd Annual San Antonio Breast Cancer Symposium - Access Pharmaceuticals, Inc.
Access Pharmaceuticals Appoints Sales and Marketing Executive - Accuray Incorporated
First CyberKnife in Belgium to be Installed at Leading University Hospital - Acesis
Acesis Introduces New Dynamic Software Solution to Help Drive Hospital Quality and Performance Improvement - Aeterna Zentaris INC.
AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine KRX-0401 for the Treatment of Patients with Advanced Multiple Myeloma - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
